Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCFinancial_Report.xls
10-Q - QUARTERLY REPORT - VENTRUS BIOSCIENCES INCv326006_10q.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR6.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR4.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR8.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR7.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR1.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR2.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR9.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR18.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR17.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR22.htm
EX-31.1 - CERTIFICATION - VENTRUS BIOSCIENCES INCv326006_ex31-1.htm
EX-32.1 - CERTIFICATION - VENTRUS BIOSCIENCES INCv326006_ex32-1.htm
EX-31.2 - CERTIFICATION - VENTRUS BIOSCIENCES INCv326006_ex31-2.htm
EX-32.2 - CERTIFICATION - VENTRUS BIOSCIENCES INCv326006_ex32-2.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR13.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR19.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR11.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR15.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR14.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR12.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR20.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR23.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR16.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR21.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR3.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR10.htm
v2.4.0.6
CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (USD $)
Total
Common Stock [Member]
Common Stock [Member]
Cashless [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Cashless [Member]
Deficit Accumulated During the Development Stage [Member]
Beginning Balance at at Dec. 31, 2011 $ 34,532,707 $ 12,406   $ 102,049,385   $ (67,529,084)
Beginning Balance (in shares) at Dec. 31, 2011   12,406,406        
Options exercised (in shares) 168,240 68,240 47,550      
Options exercised 427,817 68 48 427,749 (48) 0
Warrants exercised (in shares)   11,620        
Warrants exercised   11   (11)    
Warrants exercised from January 1, 2012 and June 30, 2012 (in shares)   45,834        
Warrants exercised from January 1, 2012 and September 30, 2012 302,505 46   302,459    
Proceeds from common stock sold (at an average $12.45 per share), net of costs (in shares)   354,700        
Proceeds from common stock sold (at an average $12.45 per share), net of costs 4,166,494 355   4,166,139   0
Stock-based compensation for the period from January 1, 2012 to September 30, 2012 to employees and directors 2,241,659     2,241,659   0
Stock-based payments for the period from January 1, 2012 to September 30, 2012 to consultants 326,313 0   326,313    
Net loss (20,999,321)         (20,999,321)
Ending Balance at at Sep. 30, 2012 $ 20,998,174 $ 12,934   $ 109,513,645   $ (88,528,405)
Ending Balance (in shares) at Sep. 30, 2012   12,934,350